Business Context and Reporting Period
Healthcare Triangle, Inc. (HCTI), a Delaware corporation listed on The Nasdaq Stock Market, filed this Form 8-K on June 12, 2026. The report details the completion of a private placement of senior convertible promissory notes and the entry into an equity line of credit agreement to secure liquidity.
Key Financial Metrics and Capital Structure
- Debt Financing: Issued $4.235 million in aggregate principal amount of 15% original issue discount senior convertible promissory notes.
- Cash Proceeds: Generated approximately $3.6 million in gross proceeds from the note offering before fees and expenses.
- Debt Maturity: Notes mature on December 12, 2026.
- Equity Line Capacity: Established an equity purchase agreement allowing for the sale of up to $50,000,000 in common stock over a 36-month period.
- Warrant Issuance: Issued a warrant to purchase up to 50,000 shares of common stock at an exercise price of $0.00001 per share.
Material Changes and Transaction Terms
The filing reports two significant capital-raising transactions executed on June 12, 2026:
- Convertible Notes: The notes carry a 15% interest rate and are convertible into common stock at 85% of the volume-weighted average price, subject to a floor price of $0.452 per share. The company may prepay the notes at 102.5% of the outstanding principal plus accrued interest. Additionally, the company must repay 25% of net proceeds from certain future financing transactions.
- Equity Line: The company may require the investor (Hudson Global Ventures, LLC) to purchase shares in minimum increments of $25,000. The purchase price is set at 94% of the average of the three lowest traded prices during the five trading days preceding the put date.
Guidance, Risks, and Contingencies
- Shareholder Approval Risk: Conversion of the notes is subject to Nasdaq shareholder approval limitations. Failure to obtain required stockholder approval by December 12, 2026, will constitute an event of default, triggering liquidated damages.
- Registration Requirements: The company must file a registration statement for the equity line shares within 45 days and have it declared effective within 90 days. The ability to sell shares is contingent on this effectiveness and other conditions, including a 4.99% beneficial ownership limitation.
- Forward-Looking Statements: The filing includes standard disclaimers regarding risks and uncertainties that could cause actual results to differ from expectations, referencing risk factors in the March 31, 2025, Form 10-K.
Investor Verification Checklist
- Verify the exact amount of placement agent fees and offering expenses deducted from the $3.6 million gross proceeds to determine net cash received.
- Confirm the current trading price of HCTI common stock relative to the $0.452 conversion floor price and the 85% conversion discount.
- Review the status of the registration statement for the $50 million equity line to ensure it is effective and available for resale.
- Assess the company's ability to meet the December 12, 2026, deadline for shareholder approval to avoid default on the convertible notes.
- Examine the "Risk Factors" section of the most recent Form 10-K for specific operational and financial risks associated with these financing structures.